SHANGHAI, Sept. 25,
2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD)
("Zhongchao" or the "Company"), a platform-based internet
technology company offering services for patients with cancer and
other major diseases, today announced the introduction of its
Patient-Reported Outcome (PRO) -based symptom management model.
This model is geared toward aiding the recovery of lung cancer
patients and enhancing their life quality.
Many lung cancer patients are grappling with a multitude of
symptoms throughout their treatment process, including but not
limited to fatigue, reduced appetite, nausea, and approximately 34
other symptoms. These symptoms can lead to emotional turmoil
towards patients, manifesting as anxiety or depression, severely
impacting patients' life quality and their overall recovery
process. The PRO-based symptom management method prioritizes
genuine feedbacks from patients about their health conditions,
which aids in accurately identifying underlying health concerns and
enhancing overall well-being. A study published in the "Journal of
Clinical Oncology" in 2022 also highlighted that a PRO-driven model
integrating proactive Symptom Monitoring, Alerting, and Response
System can significantly reduce post-discharge symptoms and
complications in lung cancer patients, accelerate their
post-operative recovery and receive high satisfaction from
patients.
Zhongchao's existing patient management services already
features a comprehensive range of offerings for lung cancer
patients. The expert-led seminars could guide patients and offer
direct engagement through mobile applications to answer their
queries virtually. The seminars ensure patients fully understand
their treatment journey and can enhance their adherence to
treatment protocols. Zhongchao also provides a suite of resources
through mobile applications, including, among the others,
educational contents, disease follow-up visits, lifestyle advice,
drug aids information and other support services. To facilitate
efficient and one-on-one patient communications, Zhongchao has
established robust follow-up channels through various platforms
such as telephones, WeChat, and text messages, staffed by dedicated
disease management specialists. Unlike the existing patient
management services, which focus primarily on medical aspects such
as Duration of Therapy, the newly introduced PRO-based management
model shifts the focus towards patients' own experiences and
feelings about their health, bringing a fresh perspective into
patient care. By actively collecting and analyzing patient
feedbacks on physical symptoms, emotional states, self-perceptions
and other PRO data, the Company is able to continually refine its
management methods, aiming to enhance the living standards and
well-being of lung cancer patients.
Weiguang Yang, Chairman and Chief
Executive Officer of Zhongchao, commented, "We believe that
PRO-based symptom management method provides an invaluable way to
detect lung cancer patients' underlying health issues accurately
and comprehensively, assist clinical decisions and improve the
quality of care for our lung cancer patients. At Zhongchao, we are
continually refining our approaches to patient management services,
aiming to achieve meaningful and lasting impacts on the lives of
cancer patients."
About Zhongchao Inc.
Zhongchao Inc. is an offshore holding company incorporated in
the Cayman Islands. It
consolidates the financial results of a variable interest entity,
Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries (the
"PRC operating entities") through a series of contractual
arrangements. Zhongchao Inc. is a platform-based internet
technology company offering services to patients with oncology and
other major diseases. The PRC operating entities provide online
healthcare information, professional training and educational
services to healthcare professionals under their "MDMOOC" platform
(www.mdmooc.org), offer patient management services in the
professional field of tumor and rare diseases through Zhongxin,
offer internet healthcare services through Zhixun Internet
Hospital, and pharmaceutical services through Xinjiang Medical and
operate an online information platform, Sunshine Health Forums, to
general public. More information about the Company can be found at
its investor relations website at http://izcmd.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's goals and strategies; the Company's future
business development; product and service demand and acceptance;
changes in technology; economic conditions; the growth of the
professional training and educational services market in
China and the other international
markets the Company plans to serve; reputation and brand; the
impact of competition and pricing; government regulations;
fluctuations in general economic and business conditions in
China and the international
markets the Company plans to serve and assumptions underlying or
related to any of the foregoing and other risks contained in
reports filed by the Company with the SEC, the length and severity
of the recent coronavirus outbreak, including its impacts across
our business and operations. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC, which
are available for review at www.sec.gov. The Company undertakes no
obligation to publicly revise these forward–looking statements to
reflect events or circumstances that arise after the date
hereof.
For more information, please contact:
At the Company: Pei Xu, CFO
Email: xupei@mdmooc.org
Phone: +86 13901629242
Investor Relations: Sherry Zheng
Weitian Group LLC
Email: shunyu.zheng@weitian-ir.com
Phone: +1 718-213-7386
View original
content:https://www.prnewswire.com/news-releases/zhongchao-inc-introduces-pro-based-disease-management-model-for-lung-cancer-patients-301936650.html
SOURCE Zhongchao Inc.
